Scientists uncover a new doorway for SARS-CoV-2 into human cells

Research identifies the human transferrin receptor as an alternative pathway for SARS-CoV-2 infection, offering potential new targets for COVID-19 therapies.

CD123-targeted CAR-NK by Chongqing Precision Biotech for Refractory Acute Myeloid Leukemia: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

September 14, 2023

Latest advancements and challenges in the use of cross-frequency coupling for neuroscience

A review paper by researchers at the Beijing Institute of Technology summarized recent advancements and challenges in the use of cross-frequency coupling (CFC) for neuroscience

June 29, 2023

GC Therapeutics secures $65m to launch into off-the-shelf iPSC therapy space – Pharmaceutical Technology

GC Therapeutics (GCTx) has launched itself into the cell therapy space to develop pluripotent stem cell (iPSC)-based medicines. Credit: eamesBot via Shutterstock. GC Therapeutics (GCTx)

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.